Genotypic diversity in clinical and environmental isolates of Cryptococcus neoformans from India using multilocus microsatellite and multilocus sequence typing
- PMID: 31820495
- DOI: 10.1111/myc.13041
Genotypic diversity in clinical and environmental isolates of Cryptococcus neoformans from India using multilocus microsatellite and multilocus sequence typing
Abstract
Background: Cryptococcus neoformans is the leading cause of cryptococcal meningitis in HIV/AIDS patients. As infections in humans are predominantly caused by the inhalation of basidiospores from environmental sources, therefore, analysing the population structure of both clinical and environmental populations of C neoformans can increase our understanding of the molecular epidemiology of cryptococcosis.
Objective: To investigate the genotypic diversity and antifungal susceptibility profile of a large collection of C neoformans isolates (n = 523) from clinical and environmental sources in India between 2001 and 2014.
Materials and methods: Cryptococcus neoformans isolates were genotyped by AFLP, microsatellite typing (MLMT) and MLST. In vitro antifungal susceptibility for standard antifungals was undertaken using CLSI M27-A3.
Results: All isolates were C neoformans, AFLP1/VNI and exhibited mating-type MATα. MLMT revealed that the majority of isolates belonged to microsatellite cluster (MC) MC3 (49%), followed by MC1 (35%), and the remaining isolates fell in 11 other MC types. Interestingly, two-thirds of clinical isolates were genotype MC3 and only 17% of them were MC1, whereas majority of environmental strains were MC1 (54%) followed by MC3 (16%). Overall, MLST assigned 5 sequence types (STs) among all isolates and ST93 was the most common (n = 76.7%), which was equally distributed in both HIV-positive and HIV-negative patients. Geometric mean MICs revealed that isolates in MC1 were significantly less (P < .05) susceptible to amphotericin B, 5-flucytosine, itraconazole, posaconazole and isavuconazole than isolates in MC3.
Conclusions: The study shows a good correlation between MLMT and MLST genotyping methods. Further, environmental isolates were genetically more diverse than clinical isolates.
Keywords: Cryptococcus neoformans; AFST; India; MLMT; MLST; multilocus microsatellite typing.
© 2019 Blackwell Verlag GmbH.
Similar articles
-
Molecular characterization and antifungal susceptibility testing of Cryptococcus neoformans sensu stricto from southern Brazil.J Med Microbiol. 2018 Apr;67(4):560-569. doi: 10.1099/jmm.0.000698. Epub 2018 Feb 20. J Med Microbiol. 2018. PMID: 29461182
-
Antifungal susceptibility and multilocus sequence typing (MLST) of Cryptococcus neoformans complex from HIV-associated cryptococcal meningitis patients in Manaus, Amazonas, Brazil.Braz J Microbiol. 2024 Sep;55(3):2603-2611. doi: 10.1007/s42770-024-01378-y. Epub 2024 May 16. Braz J Microbiol. 2024. PMID: 38755408 Free PMC article.
-
Molecular epidemiology and in vitro antifungal susceptibility testing of 108 clinical Cryptococcus neoformans sensu lato and Cryptococcus gattii sensu lato isolates from Denmark.Mycoses. 2016 Sep;59(9):576-84. doi: 10.1111/myc.12507. Epub 2016 Apr 8. Mycoses. 2016. PMID: 27061834
-
Cryptococcal meningitis due to Cryptococcus neoformans genotype AFLP1/VNI in Iran: a review of the literature.Mycoses. 2015 Dec;58(12):689-93. doi: 10.1111/myc.12415. Epub 2015 Oct 7. Mycoses. 2015. PMID: 26444438 Review.
-
Environmental prevalence of Cryptococcus neoformans and Cryptococcus gattii in India: an update.Crit Rev Microbiol. 2012 Feb;38(1):1-16. doi: 10.3109/1040841X.2011.606426. Epub 2011 Dec 1. Crit Rev Microbiol. 2012. PMID: 22133016 Review.
Cited by
-
Associations between Cryptococcus Genotypes, Phenotypes, and Clinical Parameters of Human Disease: A Review.J Fungi (Basel). 2021 Mar 30;7(4):260. doi: 10.3390/jof7040260. J Fungi (Basel). 2021. PMID: 33808500 Free PMC article. Review.
-
Clinical epidemiology and high genetic diversity amongst Cryptococcus spp. isolates infecting people living with HIV in Kinshasa, Democratic Republic of Congo.PLoS One. 2022 May 19;17(5):e0267842. doi: 10.1371/journal.pone.0267842. eCollection 2022. PLoS One. 2022. PMID: 35587939 Free PMC article.
-
Molecular Markers Reveal Epidemiological Patterns and Evolutionary Histories of the Human Pathogenic Cryptococcus.Front Cell Infect Microbiol. 2021 May 6;11:683670. doi: 10.3389/fcimb.2021.683670. eCollection 2021. Front Cell Infect Microbiol. 2021. PMID: 34026667 Free PMC article. Review.
-
Genotypic diversity of Iranian Cryptococcus neoformans using multilocus sequence typing (MLST) and susceptibility to antifungals.Mol Biol Rep. 2021 May;48(5):4201-4208. doi: 10.1007/s11033-021-06433-7. Epub 2021 May 31. Mol Biol Rep. 2021. PMID: 34057687
-
Cryptococcal Immune Reconstitution Inflammatory Syndrome: From Blood and Cerebrospinal Fluid Biomarkers to Treatment Approaches.Life (Basel). 2021 Jan 27;11(2):95. doi: 10.3390/life11020095. Life (Basel). 2021. PMID: 33514007 Free PMC article. Review.
References
REFERENCES
-
- Kwon-Chung KJ, Fraser JA, Doering TL, et al. Cryptococcus neoformans and Cryptococcus gattii, the etiologic agents of cryptococcosis. Cold Spring Harb Perspect Med. 2014;4:a019760.
-
- UNAIDS. Report on the India AIDS Epidemic. [Online] Available at: https://www.unaids.org/en/regionscountries/countries/india.2017 Accessed on 02 November 2019.
-
- Rajasingham R, Smith RM, Park BJ, et al. Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis. Lancet Infect Dis. 2017;17:873-881.
-
- Maziarz EK, Perfect JR. Cryptococcosis. Infect Dis Clin North Am. 2016;30:179-206.
-
- Chowdhary A, Randhawa HS, Prakash A, Meis JF. Environmental prevalence of Cryptococcus neoformans and C gattii in India: an update. Crit Rev Microbiol. 2012;38:1-16.
MeSH terms
Substances
Associated data
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials